REG - capAI PLC - Exercise of Warrants

capAIAnnouncement

Thu 07:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260507:nRSG3047Da&default-theme=true

RNS Number : 3047D  capAI PLC  07 May 2026

THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN IS RESTRICTED AND IS
NOT FOR PUBLICATION, RELEASE OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE
OR IN PART, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, JAPAN, SINGAPORE,
THE REPUBLIC OF SOUTH AFRICA OR ANY OTHER JURISDICTION IN WHICH SUCH
PUBLICATION, RELEASE OR DISTRIBUTION WOULD BE PROHIBITED BY ANY APPLICABLE
LAW.

7 May 2026

 capAI plc

 (the "Company")

Exercise of Warrants

capAI plc (LSE: CPAI, OTCQB: CPIQF) announces that it has received notice of
exercise of warrants ("Warrants") to subscribe for a total of 5,290,000 new
ordinary shares of nominal value £0.0001 each in the capital of the Company
("New Ordinary Shares"). The total consideration paid to the Company in
connection with the exercise of such Warrants is £19,838.

 

The New Ordinary Shares will rank pari passu with the existing Ordinary Shares
and application has been made for the New Ordinary Shares to be admitted to
the equity shares (transition) category of the Official List of the Financial
Conduct Authority ("FCA") and to trading on the main market for listed
securities of London Stock Exchange plc ("Admission"). It is expected that
Admission will become effective and dealings in the New Ordinary Shares will
commence at 8.00 a.m. on 13 May 2026.

 

Total Voting Rights

 

Upon Admission of the New Ordinary Shares, the Company's issued share capital
will consist of 426,433,063 Ordinary Shares with one voting right each. The
Company does not hold any Ordinary Shares in treasury. Therefore, the total
number of voting rights in the Company will be 426,433,063. With effect from
Admission, this figure may be used by shareholders in the Company as the
denominator for the calculations by which they will determine if they are
required to notify their interest in, or a change to their interest in, the
share capital of the Company under the FCA's Disclosure Guidance and
Transparency Rules.

 

Conditional Awards/Share Options

 

In accordance with the anti-dilution provisions announced on 12 March 2025
(RNS Number: 2759A), Professor Ronjon Nag has been granted additional
conditional awards ("Conditional Awards") over 2,542,370 Ordinary Shares, and
Richard Andrew Edwards has been granted additional share options ("Share
Options") over 423,728 Ordinary Shares, on identical terms to those granted in
the announcement of 12 March 2025.

 

The additional grants of Conditional Awards and Share Options have been made
pursuant to the Company's anti-dilution provisions to preserve the respective
proportional entitlements of Professor Ronjon Nag and Richard Andrew Edwards
under their existing Conditional Award and Share Option arrangements,
consistent with their previous percentage interests in the Company's enlarged
issued share capital, taking into account the exercise of the 5,290,000
Warrants referred to above.

 

Enquiries

 

Company:

capAI plc hello@capaiplc.com

 

Broker:

AlbR Capital Limited Tel: +44 (0) 207 469 0930

 

The information set out below is provided in accordance with the requirements
of Article 19(3) of Regulation 2014/596/EU, which is part of the domestic law
of the United Kingdom of Great Britain and Northern Ireland pursuant to the
Market Abuse (Amendment) (EU Exit) Regulations (SI 2019/310).

 

 1   Details of the person discharging managerial responsibilities / person closely
     associated
 a)  Name                                                         Professor Ronjon Nag
 2   Reason for Notification
 a)  Position/status                                              Executive Director, PDMR
 b)  Initial notification/amendment                               Initial notification
 3   Details of the issuer, emission allowance market participant, auction
     platform, auctioneer or auction monitor
 a)  Name                                                         capAI plc
 b)  LEI                                                          213800IVPZ932NP24O44
 4   Details of the transaction(s): section to be repeated for (i) each type of
     instrument; (ii) each type of transaction; (iii) each date; and (iv) each
     place where transactions have been conducted
 a)  Description of the financial instrument, type of instrument  Ordinary shares of £0.0001 each nominal value
     Identification code                                          ISIN: GB00BV2FG348
 b)  Nature of the transaction                                    Grant of Conditional Awards with share price appreciation and tenure vesting
                                                                  conditions
 c)  Price(s) and volume(s)                                       Price(s)                     Volume(s)
                                                                  £0.0001 per Ordinary Share   2,542,370
 d)  Aggregated information
     - Aggregated volume                                          n/a
     - Price
 e)  Date of the transaction                                      6 May 2026
 f)  Place of the transaction                                     Outside a trading venue

d)

Aggregated information

- Aggregated volume

n/a

- Price

e)

Date of the transaction

6 May 2026

f)

Place of the transaction

Outside a trading venue

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  MSCEAKSKEEEKEFA



            Copyright 2019 Regulatory News Service, all rights reserved